Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,333.41
    -1,117.23 (-2.13%)
     
  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

US High-Performance Liquid Chromatography (HPLC) Market Report 2021: Growth in the R&D Investment by Pharmaceutical and Research Institutes & Growing Demand for HPLC in Drug Discovery Activities

Dublin, June 03, 2021 (GLOBE NEWSWIRE) -- The "US High-Performance Liquid Chromatography (HPLC) Market 2020-2026" report has been added to ResearchAndMarkets.com's offering.

The US high-performance liquid chromatography (HPLC) market is estimated to grow at a CAGR of 4.6% during the forecast period

The market is mainly driven due to various pivotal factors such as significant growth in the R&D investment by the pharmaceutical and research institutes, growing demand for HPLC in drug discovery activities, and the presence of major biotechnology companies in the country.

As per the research America from 2017 to 2018, medical and health R&D spending in the US grew by 6.4%, reaching $194.2 billion. Therefore, the growing R&D investment in medical health R&D further provides a significant opportunity for the market. However, the high cost of HPLC equipment is further estimated to restrain market growth during the forecast period.

The consumables segment is estimated to hold a significant growth in the US HPLC market owing to the growing application of consumables in clinical research applications. Based on the application, the US HPLC market is further segmented into diagnostics, clinical research, forensics, and others. The clinical research segment is estimated to grow at a considerable CAGR during the forecast.

Furthermore, the US HPLC market is characterized by the presence of several market players that are catering to a wide range of customers in the region.

Some of the key players in the market include Agilent Technologies, Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Waters Corp., Bio-Rad Laboratories, Inc., Gilson Inc., and others.

ADVERTISEMENT

These players adopt various strategies to remain competitive in the market and gain a competitive advantage over other players operating in the market. Mergers and acquisitions, product launches, and partnerships and collaborations, and geographical expansion are some of the major activities adopted by the market players.

Key Topics Covered:

1. Report Summary

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.3. Rules & Regulations

3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities

4. Market Segmentation
4.1. US HPLC Market by Product Type
4.1.1. Consumables
4.1.2. Instruments
4.1.3. Accessories
4.2. US HPLC Market by Application
4.2.1. Diagnostics
4.2.2. Clinical Research
4.2.3. Forensics
4.2.4. Others (Testing)

5. Company Profiles
5.1. Agilent Technologies, Inc.
5.2. AB SCIEX, LLC
5.3. Bio-Rad Laboratories, Inc.
5.4. Gilson Inc.
5.5. JASCO
5.6. Orochem Technologies Inc.
5.7. PerkinElmer Inc.
5.8. Phenomenex Inc.
5.9. Restek Corp.
5.10. SIELC Technologies
5.11. Thermo Fisher Scientific Inc.
5.12. Waters Corp.

For more information about this report visit https://www.researchandmarkets.com/r/2ib3iz

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900